GE HealthCare (Nasdaq: GEHC) has announced that its updated Voluson™ Expert Series ultrasound systems have received 510(k) clearance from the U.S. Food and Drug Administration (FDA). According to the company, the latest Voluson Expert 22, 20, and 18 models integrate artificial intelligence (AI) capabilities, advanced imaging tools, and an ergonomic design aimed at improving workflow efficiency and diagnostic precision in women’s healthcare.
The company claims that the Voluson Expert Series is designed to enhance early detection and diagnostic confidence, particularly in high-risk pregnancies. With approximately 30,000 to 50,000 women in the U.S. experiencing complex pregnancies each year, the need for advanced imaging solutions that facilitate timely intervention is significant.
Advancing Early Detection with AI and Imaging Enhancements
GE HealthCare states that the Voluson Expert Series incorporates its proprietary Lyric Architecture, which enhances imaging and processing power to provide clearer, more detailed anatomical views—even in challenging scanning conditions. The company asserts that this level of precision can aid in the early identification of potential complications, offering clinicians the ability to make more informed decisions.
One of the key features, the SonoLyst AI suite, utilizes image recognition technology to automate annotations and measurements, which the company says can streamline exam procedures and improve accuracy. The latest iteration, SonoLystlive, is designed to assist clinicians during 11-to-14-week anatomical exams by ensuring required views are captured in real time, potentially improving diagnostic accuracy.
In addition to AI-driven enhancements, the Voluson Expert Series includes an expanded color Doppler function called Graphicflow. According to GE HealthCare, this feature visualizes complex blood flow dynamics with greater clarity, helping clinicians differentiate between normal and abnormal hemodynamics more effectively.
Optimizing Workflow Efficiency in Women’s Health
The company highlights several AI-powered automation tools that aim to reduce exam times and improve workflow efficiency. Among them is SonoPelvicFloor3.0, which GE HealthCare claims can cut pelvic floor measurement exam time by up to 80%. This tool reportedly simplifies the process by automating plane alignment, live C-plane tracking, and key measurements.
Another feature, SonoAVCfollicle2.0, is designed to enhance the accuracy of follicle detection while reducing artifacts and post-processing time. According to the company, this could improve success rates in fertility assessments and treatments.
To complement its advanced imaging capabilities, the Voluson Expert Series supports a variety of specialty probes, including the new lightweight 2D/3D probe RAB7-D and the wireless Vscan Air™ dual probes, which GE HealthCare suggests offer added flexibility for clinicians.
Industry Response and Future Outlook
“We are proud to introduce these updates to the Voluson Expert ultrasound systems, which represent our ongoing commitment to advancing technology that addresses women’s health needs of today and the future,” said Gerald Seifriedsberger, General Manager of Women’s Health, Advanced Visualization Solutions at GE HealthCare. “By introducing solutions that offer unparalleled clarity and detail, we can empower users with critical insights for informed care decisions and efficient exams, transforming how clinicians approach healthcare.”
The company plans to showcase the Voluson Expert Series at the Society for Maternal-Fetal Medicine (SMFM) 2025 Pregnancy Meeting™, which runs from January 27 to February 1 in Denver. The systems are currently available in the United States.
As AI continues to reshape medical imaging, GE HealthCare’s latest release signals a broader industry shift toward automation and precision in diagnostics. Whether these enhancements will significantly impact patient outcomes remains to be seen, but the company remains confident in its ability to set new standards in women’s health ultrasound technology.